Schizophrenia study: Iloperidone
Official title Randomized Withdrawal Study in Patients With Schizophrenia
ClinicalTrials.gov ID: NCT06961968
What this study is testing
What is iloperidone?
iloperidone is an investigational medicine, given as an injectable medicine, being studied as a potential treatment for schizophrenia.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study aims to find out if a specific long-acting injection is better than a fake shot at stopping symptoms from getting worse.
- Who it's for
- The study is looking for adults who have been diagnosed with schizophrenia.
- What's involved
- Participants will receive either the real long-acting injection or a placebo (a shot with no medicine) and be monitored for changes in their symptoms.
- Time commitment
- The source text does not specify the total duration or the number of required visits.
- Phase 3: a large, late-stage study
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Males or females 18 to 65 years of age (inclusive)
- Diagnosed with schizophrenia per DSM-5 criteria
- In need of ongoing psychiatric treatment
You likely can't join if
- DSM-5 diagnosis of a psychiatric disorder other than schizophrenia that was the primary focus of treatment within the previous six months
The study team makes the final eligibility decision.
Where it is enrolling
- Rogers, Arkansas, United States
- Costa Mesa, California, United States
- Lemon Grove, California, United States
- Oceanside, California, United States
- Pico Rivera, California, United States
- San Diego, California, United States
- Walnut Creek, California, United States
- North Miami, Florida, United States
- Atlanta, Georgia, United States
- Peachtree Corners, Georgia, United States
- Chicago, Illinois, United States
- Flowood, Mississippi, United States
- Saint Charles, Missouri, United States
- St Louis, Missouri, United States
- Las Vegas, Nevada, United States
- Marlton, New Jersey, United States
- Staten Island, New York, United States
- Austin, Texas, United States
- Houston, Texas, United States
- Irving, Texas, United States
+ 2 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Rogers, Arkansas, United States; Costa Mesa, California, United States; Lemon Grove, California, United States; Oceanside, California, United States; Pico Rivera, California, United States; San Diego, California, United States and 16 more locations. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.